Minerva Neurosciences, Inc. - 10-Q Filing
Minerva Neurosciences reports Q3 2026 financial results featuring significant warrant liability valuations and ongoing equity programs.
Tickers: $NERV
Read the full article at SEC EDGAR
Part of the story Minerva Neurosciences, Inc. - 10-Q Filing (3 articles)